CardioFocus Advances Quick AF Study with First-in-Human Treatments Using QuickShot Nav, a Mapping-Enabled Balloon-Based Focal PFA System

Apr 17, 2025 22:16 CST Updated 22:16

CardioFocus

Cardiac Medical Device Manufacturer

CardioFocusAnnounce the continuation of the Quick AF study, aimed at evaluating itsWith mapping functionBalloon-shaped large focal PFA productQuickShot NavEffectiveness in treating patients with persistent atrial fibrillation (AF).

PI Evaluation

"The versatility of the QuickShot Nav catheter allows for both mapping and ablation to be performed with a single device. Its design ensures precision while significantly reducing the number of maneuvers required by traditional methods, offering physicians the flexibility to plan lesion placement. This innovation is expected to bring significant changes to clinical practice."

---Ante Anić KBC Split

Executive Evaluation

"We thank Dr. Anić's team for their significant contributions and look forward to the continued breakthroughs of QuickShot Nav. The company’s PFA strategy, rooted in extensive research on proprietary waveforms, has now evolved into a complete ecosystem of tools to help physicians improve treatment outcomes. This advancement marks a new milestone in the safe and effective treatment of atrial fibrillation."

---Steve Ogilvie CEO of CardioFocus

CardioFocusOnce rose to prominence in the electrophysiology field with HeartLight, securing substantial capital support (including from Yuanda). However, with the rise of PFA,The HeartLight laser ablation technology has lost its competitive advantage. Therefore,CardioFocusEmbarking on a comprehensive transformation, building a full range of PFA technology portfolios. Last yearCardioFocusAcquisition of Galvanize Therapeutics' ElectrophysiologyTechnical Department, thereby PFA Energy PlatformCENTAURI PEFAndQuickShot Nav. At the same timeCardioFocusAlso based onDevelopment of HeartLight's Compliant Balloon TechnologyOptiShot PFA Balloon for Single Pulmonary Vein Isolation. These technical components nowCardioFocusPFA Solution.

CardioFocusThe ablation catheters are all based on balloon-shaped ablation catheters. InIn the field of balloon-shaped ablation catheters,CardioFocus, Abbott andCardioFocus has become a leader in this field. Currently, Abbott is the fastest (Volt PFA has received CE approval.CardioFocus is second only to HeartPath. HoweverCardioFocusPFA Energy PlatformCENTAURIPEF is the second approved PFA product and has been on the market for three years.

CardioFocusWithCENTAURI PEF、QuickShot Nav、OptiShot PFA Still Has Hope to Stand Out.

QuickShot Nav

QuickShot NavThe catheter is a highly versatile ablation catheter, compatible withPFA Energy PlatformUsed together with CENTAURI PEF.QuickShot NavThe multifunctional design makes the PVI+ (Pulmonary Vein Isolation and Extension) ablation process efficient and operationally simplified during ablation, allowing for flexible lesion planning with fewer procedural steps. It is equipped with a magnetic navigation sensor and is compatible with a magnetic positioning electrophysiological mapping system.

And with maturityCENTAURI PEFUsed in conjunction, allowingQuickShot NavIt has become safer during the ablation process. CurrentlyCENTAURIPEF has been used forThousands of patients treated.

CENTAURI PEFHas several major technological advantages over competitors:

Proprietary WAVE1 technology reduces muscle stimulation and eliminates microbubbles that can cause strokes in other electrical pulse ablation products (this is very critical).
The proprietary CENTAURI connector allows physicians to perform electropulse ablation procedures using their currently commonly used radiofrequency ablation catheters or mapping catheters, saving training time, workflow adjustments, and costs.
CENTAURI PEFProvide ThreeA type of energy setting that allows doctors to select the appropriate energy for specific target tissues.

CardioFocus

CardioFocusIs a medical device innovator and manufacturer dedicated to advancing ablation treatments for the most common arrhythmias, such as atrial fibrillation (AFib).HeartLightIt is a revolutionary catheter ablation technology characterized by a super-compliant balloon, direct visualization, and titratable laser energy, representing a new standard for AFib ablation.